A widely practiced, stress-reducing meditation technique significantly decreases the severity of congestive heart failure, according to a first-of-its-kind randomized study published in Ethnicity & Disease (Winter 2007).
A national survey of commercial health plans has found that most plans provide online information regarding mental health and substance abuse but few provide clinical services such as counseling via the Internet.
In clinical studies for the lead indication of multiple sclerosis (MS), Revimmune improves function in most patients and stops progression in over 90 percent of cases refractory to standard therapies.
The Texas Department of State Health Services (DSHS) is now testing “heel stick” blood samples from newborns for 26 disorders, with a 27th to be added this year.
“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
A new study being published by the American Physiological Society finds that the body responds differently to colitis (inflammation of the colon) based on whether the disease is acute (sharp and brief) or chronic (long-term).
Eli Lilly and Company today announced the launch of the first insulin pen with memory, HumaPen? MEMOIR?, to help simplify the daily management of diabetes.
Diabetes management can be overwhelming, and data shows less than half of the 15 million being treated for diabetes have blood sugar levels within the recommended range.
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the New England Journal of Medicine.
US FDA directs ADHD drugmakers to notify patients about cardiovascular adverse events and psychiatric adverse events from the use of ADHD drugs.